The list of publications in 2014
1. Ionova T.I. Quality of life and hypoglycemia burden in patients with type 2 diabetes mellitus on basal-bolus insulin therapy / T.I. Ionova, V.I. Odin, T.P. Nikitina, K.A. Kurbatova // Clinical Medicine. – 2014. – Vol. 92 (10): 52-59. (In Russian)
2. Shevchenko Y.L. Quality of life before autologous stem cells transplantation as prognostic factor in patients with malignant / Y.L. Shevchenko, D.A. Fedorenko, V.Y. Melnichenko, N.Y. Mochkin, T.I. Ionova, A.A. Novik // Lymphomas Oncohematology. – 2014. – Vol. 9 (1):19-24. DOI:10.17650/1818-8346-2014-9-1-19-24 (In Russian)
3. Mochkin N.E. Quality of Life of Patients with Lymphomas at Different Time-Points after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation / N.E. Mochkin, D.A. Fedorenko, V.Y. Melnichenko, T.I. Ionova, T.P. Nikitina, KA. Kurbatova, AA. Novik // Clinical Oncohematology. Basic Research and Clinical Practice. – 2014. – Vol. 7 (4): 577-582. (In Russian)
4. Ionova T.I. Value of Patient-Reported Outcomes / T.I. Ionova, S. Salek, Å. Oliva // Clinical Oncohematology. Basic Research and Clinical Practice. – 2014. – Vol. 7 (4): 573-576. (In Russian)
5. Ionova T.I. Fear of hypoglycemia in patients with 2 type diabetes mellitus receiving basal-bolus insulin therapy / T. I. Ionova, V. I. Odin, T. P. Nikitina, K. A. Kurbatova // Bulletin of the Multinational Center of Quality of Life Research. – 2014. – Vol. 23-24: 13-23. (In Russian)
6. Ionova T.I. Changes of symptoms related with hand-foot syndrome in patients with solid tumors receiving antitumor therapy with or without using the new antioxidant-containing topical formulation Elima®/ T.I. Ionova, T.P. Nikitina, K.A. Kurbatova, I.S. Bazin, A.V. Belonogov, G.P. Kolesnikov, M.V. Panina, P.S. Borisov // Bulletin of the Multinational Center of Quality of Life Research. – 2014. – Vol. 23-24: 41-50. (In Russian)
7. Ionova T.I. Validation of Comprehensive Symptom Profile Questionnaire for patients with Chronic Myeloid Leukemia – CSP Leuk-CML / T.I. Ionova, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova, E.I. Usacheva // Bulletin of the Multinational Center of Quality of Life Research. – 2014. – Vol. 23-24: 72-85. (In Russian)
8. Komlyonok N.M. Adaptive capabilities in diabetic patients: the value of the psychological status / N.M. Komlyonok, T.I .Ionova // Bulletin of the Multinational Center of Quality of Life Research. – 2014. – Vol. 23-24: 86-92. (In Russian)
9. Ionova T I. Quality of life in patients with chronic myeloid leukemia in long-term follow-up of second-line dasatinib treatment / T.I. Ionova, T.P. Nikitina, G.B. Kuchma, T.V. Shneider, I.V. Sannikova, E.I. Usacheva, K.A. Kurbatova // Bulletin of the Multinational Center of Quality of Life Research. – 2014. – Vol. 23-24: 93-96. (In Russian)
10. Kurbatova K. A. Multivariate statistical methods in medical studies of quality of life / K.A. Kurbatova, T.I. Ionova, A.V. Kishtovich // Bulletin of the Multinational Center of Quality of Life Research. – 2014. – Vol. 23-24: 97-102.
11. Nikitina T.P. The effectiveness of Elima gel film in comparison with standard treatment with Vitamin F99 cream in patients with palmar-plantar syndrome developed against the background of antitumor therapy: the results of a pilot multicentre study / T.P. Nikitina, I.S. Bazin, G.P. Kolesnikov, M.V. Panina, P.S., K.A. Borisov, T.I. Ionova, K.A. Kurbatova // Malignant tumours. – 2014. – Vol. 3: 196-197. (In Russian)
12. Ionova T.I. Questionnaire for a full-scale evaluation of symptoms in patients with chronic myelogenous leukemia - Csp Leuk-CML: results of a validation study / T.I. Ionova, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova // XI International Symposium "Hematopoietic Stem Cell Transplantation. Gene and Cellular Therapy", in memory of Raisa Gorbachev. (In Russian)
13. Ionova T.I. Base-line Quality of Life Impairment and Its Potential Prognostic Value in Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (AHSCT) / T.I. Ionova, V.Y. Melnichenko, D.A. Fedorenko, T.P. Nikita, E. Mochkin, K.A.Kurbatova, G. Gorodokin, A.A. Novik.// Bone Marrow Transplantation. 2014. Vol. 49 (Suppl. 1, March): 170.
14. Nikitina T.P. Comprehensive symptom profile in patients with chronic myeloid leukemia: practicability and sensitivity of the new symptom assessment tool CSP Leuk-CML / T.P. Nikitina, D.A. Fedorenko, K.A. Kurbatova, E.I. Usacheva, T.I. Ionova, G.I. Gorodokin, A.A. Novik // Haematologica. 2014 (Suppl.): B1674.
15. Ionova T.I. The value of dasatinib therapy in patients with imatinib-resistant or -intolerant chronic myeloid leukemia from physician's and patient's perspective: "real world" outcomes / T.I. Ionova, T.P. Nikitina, T.A. Gritsenko, V.L. Ivanova, G.B. Kuchma, T.V. Shnaider, I.V. Sannikova, E.I. Usacheva, D.A. Fedorenko, K.A. Kurbatova // Haematologica. 2014 (Suppl.): B1675.
16. Ionova T. The usefulness of patient treatment satisfaction questionnaire (PTSQ) in diabetes mellitus (DM) patients / T. Ionova, T. Nikitina, K. Kurbatova // Value in Health. 2014. Vol. 17 (3): A256.
17. Ionova T. Applicability of the new instrument for assessment of hypoglycemia symptoms in diabetes mellitus patients / T. Ionova, T. Nikitina, K. Kurbatova // Value in Health. 2014. Vol. 17 (3): A256.
18. Nikitina T. New antioxidant-containing topical formulation for treatment of Hand-Foot Syndrome in cancer patients: physician's and patient's perspective / T. Nikitina, T. Ionova, K. Kurbatova, I. Bazin, A. Belonogov, G. Kolesnikov, M. Panina, P. Borisov // Annals of Oncology. 2014. Vol. 25 (Suppl. 4): 517–541. doi:10.1093/annonc/mdu356.35.
19. Ionova T. Self-reporting Hand-Foot Syndrome (HFS) is practical in cancer patients with chemotherapy-induced dermatological toxicity / T. Ionova, T. Nikitina, K. Kurbatova // Quality of Life Research. 2014; 23 (Suppl. 1): 111.
20. Ionova T. Patient-centered evaluation of treatment outcomes in CML patients after 12 months of second-line treatment: quality of life and symptom burden / T. Ionova, D. Fedorenko, T. Nikitina, K. Kurbatova // Quality of Life Research. 2014; 23(Suppl. 1): 67.
21. Ionova T. I. Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician's and Patient's Perspective / T.I Ionova, T.P Nikitina, D.A Fedorenko, T.A Gritsenko, V.L Ivanova, G.B Kuchma, T.V Shnaider, I.V Sannikova, E.I. Usacheva, K.A. Kurbatova // Blood. 2014; 124 (21): À2644.
22. Nikitina T.P. Baseline Quality of Life in Chronic Phase Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Imatinib and its Potential Prognostic Value / T.P. Nikitina, D.A. Fedorenko, K.A. Kurbatova, T.A. Gritsenko, V.L. Ivanova, G.B. Kuchma, T.V. Shnaider, I.V. Sannikova, E.I. Usacheva, T.I. Ionova.// ELN Frontiers meeting. Abstracts. 2014: 21.
|
